About Actavis

North America is Actavis’s single largest market with one-third of the company’s sales generated here. Following three major acquisitions in the US since 2005 - Abrika Pharmaceuticals, Amide Pharmaceuticals and the US generic arm of Alpharma Inc.- the company is now the eighth largest generic company in the market by value and the fifth largest by volume.

CEO MESSAGE

From modest beginnings, the remarkable growth story of Actavis continues. Currently positioned among the world’s top five generic pharmaceutical companies, our ambition and performance remain consistently strong.
Our commitment to offering customers an exceptionally wide choice of high quality generics is clearly reflected in our development pipeline – one of the broadest in the industry. And our dynamic style ensures the timely delivery of trusted products, when and where they are needed.

STRATEGY
We persistently deliver new products from our strong pipeline. We are structured for growth and geared for action.
COMMITMENT
Among Actavis’ most valuable assets are the trust and confidence of
its investors, employees
and customers.
OUR VISION
To be a leading company in the development, manufacture and sale of quality generic pharmaceuticals in the international market.

FREQUENTLY ASKED QUESTIONS

What does the name Actavis mean?
What is a generic product?

View our FAQ

About Actavis

CEO MESSAGE

STRATEGY

COMMITMENT

OUR VISION

FREQUENTLY ASKED QUESTIONS